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Correspondence
A unique aminoglycoside-O-phosphorylating transferred the kanamycin resistance along
activity mediating resistance to aminoglycosides with ampicillin resistance to the recipient strain
in Escherichia colt HK 254 (F ~, R ", Lac " ) by conjugation (Table
I), at a frequency of 10 "2 and 10 " 3 respec-
Sir, tively. However, strain PS 5 alone transferred
The limitation of disc diffusion tests was resistance to tetracycline as well. The transfer
recently illustrated by a report on the failure of of resistance markers in E. coli PS 5 was
the test to detect moderate levels of resistance mediated by a plasmid that was > 54-2 kb and
to tobramycin in kanamycin-resistant strains that could be eliminated by treatment with
of Escherichia coli (Santanam, 1984). The acriflavin. The resulting derivative was
resistance in two representative strains was phenotypically susceptible to kanamycin,
found to be mediated by an amfnoglycoside- streptomycin, ampicillin and tetracycline by
O-phosphorylating enzymatic activity having disc diffusion tests (Table I). Strain PS 10, in
a novel spectrum of substrates. This report addition to a large plasmid similar to the one
presents the results of additional studies on the found in PS 5, had two other detectable
phosphorylating activity and its genetic basis in plasmids with a size of 6-1 kb and 5-4 kb.
the two strains. However, treatment of PS 10 with acriflavin
The two strains PS 5 and PS 10, having a selectively eliminated resistance only to
moderate level of resistance to gentamicin and kanamycin. The resulting derivative was
tobramycin (MICs '5 mg/1), were susceptible to phenotypically susceptible only to kanamycin,
amikacin (MIC 13 mg/1) and netilmicin (MIC but not to streptomycin, ampicillin or tetra-
6 mg/1) (National Committee for Clinical cycline. It retained all the plasmids found in the
Laboratory Standards, 1982). Both the strains wild strain, without any apparent change due
Table I. Resistance pattern of E. coli strains used in mating experiments'
E. coli strain
HK254(F",R-)
Lac-
PS 5 Lac+
PS5-HK254
PS5(E)
PS 10 Lac+
PS10-HK254
PS 10 (E)
Recipient
Donor
Trans-conj
Eliminanf1
Donor
Trans-conj
Eliminant
>S
R
R
R
S
R
R
R
K
S
R
R
S
R
R
S
"Disc diffusion test resul
AM
S
R
R
S
R
R
R
CF
S
S
S
s
R
S
R
t
C
s
s
s
s
R
s
s
T
s
R
R
S
R
S
S
°R, Resistant; S, susceptible
*S, Streptomycin; K., kanamycin; AM, ampicillin; CF, cephalothin; C, chloramphenicol; T, tetracycline
cMating was performed first by growing for 4 h at 37°C cultures of the donor and the recipient grown over-
night and diluted in brain-heart infusion (BHI) to 1:10 and 1:100 respectively. One millilitre of the donor
culture was mixed with 4-5 ml of the recipient, the volume made up to 10 ml in BHI and incubated at 37°C.
Transconjugants were selected from 100 ul samples taken after 2 h and 24 h of incubation, on Mackonkey agar
incorporating 4000 mg/1 of streptomycin and 500 mg/1 of kanamycin.
'Eliminants were selected from BHI cultures incorporating with 16 mg/1 of acriflavin stored at 37°C for 4
weeks.
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Table II. Phosphorylation of aminoglycosides by the cell extract of E. coli PS 10
Drug
Ribostamycin
Paromomycin
Neomycin
Butirosin
Kanamycin
Lividomycin
Streptomycin
Netilmicin
Amikacin
Gentamicin
Sisomicin
Tobramycin
Dibekacin
Spectinomycin
32P incorporated
°(cpm/3 nmol)
46,154
38,827
35,811
22,041
21,423
16,428
11,797
8740
8106
7722
7519
2940
2941
0
Efficiency
(%)
100
8412
77-59
47-76
46-42
35-59
25-56
18-94
17-56
16-73
16-29
6-37
6-37
0
*MIC
(mg/1)
>100
>100
>100
>100
>100
>100
>100
6
13
5
—
5
—
—
Total
inactivation
3 nmoles
3 nmoles
3 nmoles
3 nmoles
3 nmoles
3 nmoles
3 nmoles
80 pmoles
80 pmoles
80 pmoles
80 pmoles
80 pmoles
80 pmoles
not tested
° A value of 978 cpm from the control without drug has been deducted from the experimental values.
* MIC was tested by spreading a suspension of 1 x 10' to 4 x 10' cells in 100 ul of Mueller-Hinton broth on
Mueller-Hinton agar containing an aminoglycoside as described elsewhere (Santanam, 1984).
' Total inactivation was determined by the microbiological assay (Santanam & Kayser, 1976a).
to loss of the kanamycin resistance as discerned
by agarose gel electrophoresis of plasmid DNA
(Kieser, 1984).
The cell extract obtained by the osmotic
shock procedure (Santanam & Kayser, 19766),
phosphorylated ribostamycin with maximum
efficiency (Table II). The efficiency of phos-
phorylation of netilmicin and amikacin was
16% that of ribostamycin and that of tobramy-
cin and dibekacin was only 6%. Phosphoryla-
tion resulted in the inactivation of the drugs
tested in the range of 3 nmoles to 80 pmoles
(Santanam & Kayser, 1976a).
The phosphorylating activity described here
has a unique spectrum of substrates that
encompasses the spectrum of substrates of both
aminoglycoside-O-phosphotransferase (3') III
and aminoglycoside-O-phosphotransferase
(2") (Foster, 1983) both of which are usually
associated with Gram-positive organisms.
Since 3', 4'-dideoxykanamycin B (dibekacin)
and gentamicin, in addition to tobramycin,
are substrates for the enzymatic activity,
phosphorylation occurs presumably in the
deoxystreptamine moiety (ring II) or amino-
hexose HI of the aminoglycoside molecule.
Whether phosphorylation of the different
hydroxyl groups is mediated by a single novel
enzyme or by a combination of enzymes
remains to be determined, as does the exact
molecular weight of the large plasmid.
This work was presented in part at the 4th
Mediterranean Congress of Chemotherapy
held in Rhodos, Greece, during October 1984
(abstract no. 404).
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